The Antibody Lab to sign agreement with Conidia Bioscience

The Antibody Lab and Conidia Bioscience have signed an agreement under which The Antibody Lab is undertaking feasibility and assay development work on Conidia's specific proprieatary antigens.

Conidia Bioscience develops, manufactures and sells fuel tests into aviation, marine and land diesel sectors. Its suite of tests detects microbiological contamination using a fast, easy to use platform that gives results in minutes. Conidia's client base includes the world’s largest commercial airlines, globally renowned ship chandlers and surface fleet users across rail, road and agricultural sites.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)